World Coronavirus Dispatch: Nations quick to vaccinate on investors' radar

Study seeks to find effect of immune system on reinfection, Israel lifts its outdoor mask mandate, and other pandemic-related news across the globe.

Coronavirus vaccine, covid-19, vaccination
Representational image of a Covid-19 vaccine
Akash Podishetty Hyderabad
3 min read Last Updated : Apr 19 2021 | 2:14 PM IST
Coronavirus vaccination rate now on investors' radar

Investors in global financial markets are starting to put their money in places where rollouts of coronavirus vaccines have made the most progress. The British pound and the US dollar have both seen marked rises since the beginning of the year as investment money flows into the two countries, which are racing ahead of other big markets. Meanwhile, currencies in Japan, Eurozone and other emerging markets have been faltering. This trend, taking place against a backdrop of still-raging coronavirus infections, reflects strong expectations among investors that as more people get their shots economies will recover quickly. Read here

Let's look at the global statistics


Global infections: 141,422,630

Global deaths: 3,020,112

Nations with most cases: US (31,670,041), India (15,061,805), Brazil (13,943,071), France (5,350,521), Russia (4,649,044).

Israel, a world leader in vaccinations, lifts its outdoor mask mandate

Buoyed by its recent success in combating the coronavirus, Israel lifted its outdoor mask mandate, while schools fully reopened for the first time since September. The country has been taking rapid steps back to normalcy in the wake of its world-leading vaccination campaign and plummeting infection rates. About 56 percent of the Israeli population has been fully vaccinated. But, people were to continue carrying masks with them for entry into indoor public spaces, where they are still required. Daily new coronavirus infections in Israel have fallen from a peak of 10,000 in January to around 100 on some recent days. Read here


Human challenge trial will be done to study effect of immune system on reinfection

The immune response needed to protect people against reinfection with the coronavirus will be explored in a new human challenge trial. Human challenge trials involve deliberately exposing healthy people to a disease-causing organism in a carefully controlled manner. Researchers at the University of Oxford have announced that they have gained research ethics approval for a new human challenge trial involving people who have previously had coronavirus. Recruitment is expected to start in the next couple of weeks. Read here


Cambodia accused of using Covid to edge towards ‘totalitarian dictatorship’

Cambodians who break Covid rules could face 20 years in prison under a new law that human rights groups say takes the country “a step towards a totalitarian dictatorship”. The Prime minister warned that Cambodia was “on the brink of death” as a two-week lockdown was imposed to try to control the spread of the virus. Cambodia has among the fewest coronavirus cases in Asia, but an outbreak that started in late February has seen cases rise to 5,480 within two months and 38 fatalities. Read here


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story